RxDoctor Payments Data

Gerlinde Wernig, MD

Anatomic Pathology · Palo Alto, CANPI 1609049741

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 3 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Boehringer Ingelheim. That places this record below the midpoint for anatomic pathology clinicians in CA, where the typical reported total is $147.

$72in general payments, 2019–2025

Across 3 payments — averaging $23.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$72
$1,125,000in research payments, 2019–2025

Across 5 payments — averaging $225,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$1.1M

What the payments were for

  • Food & beverage$72100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim3$72

How this compares

$72 in reported general payments places this provider in the 35th percentile of 154 anatomic pathology providers in California.

See all anatomic pathology providers in California

Medicare billing

Part B allowed, 2024
$1,789
Medicare patients
18
Services billed
19

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology in Palo Alto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →